Thomas Griffith
Psychiatric/Mental Health · Long Beach, NYNPI 1013681113
Payments from drug & device makers
Across 154 payments — averaging $25.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$917
- AbbVie$446
- Alkermes, Inc.$433
- Axsome Therapeutics, Inc.$427
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$367
- Otsuka America Pharmaceutical, Inc.$240
- plus $1K from 11 others
What the payments were for
- Food & beverage$3,982100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 37 | $917 |
| AbbVie | 23 | $446 |
| Alkermes, Inc. | 22 | $433 |
| Axsome Therapeutics, Inc. | 9 | $427 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $367 |
| Otsuka America Pharmaceutical, Inc. | 7 | $240 |
| Lundbeck LLC | 9 | $210 |
| Indivior Inc. | 4 | $197 |
| Johnson & Johnson | 6 | $142 |
| E.r. Squibb & Sons, L.L.C. | 6 | $123 |
| Corium, LLC | 6 | $108 |
| Braeburn Inc. | 4 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $83 |
| Teva Pharmaceuticals USA, Inc. | 4 | $80 |
| Ironshore Pharmaceuticals Inc. | 3 | $67 |
| Tris Pharma Inc | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,982 in reported general payments places this provider in the 90th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 19 | $191 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $146 |
| Duloxetine Hcl | 18 | $130 |
| Buspirone Hcl | 12 | $71 |
| Fluoxetine Hcl | 20 | $32 |
| Clonidine Hcl | 15 | $30 |
| Zolpidem Tartrate | 12 | $10 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Long Beach
- Glenn HannDansville$1.3M
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
- Daniel BreeyearNiskayuna$149K
- Mary OlsonNew York$142K
- Elijah StevensBinghamton$131K
- Kayanna JonasFar Rockaway$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.